Enovis
Yahoo Finance • 5 days ago
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quar... Full story
Yahoo Finance • 13 days ago
3 Healthcare Stocks with Open Questions
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and as a result, the industry has faired... Full story
Yahoo Finance • 2 months ago
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (VISN [https://seekingalpha.com/symbol/VI... Full story
Yahoo Finance • 4 months ago
Canaccord Genuity Slashes PT on Enovis Corporation (ENOV) to $50 From $58
Enovis Corporation (NYSE:ENOV) is one of the best small cap stocks to buy with huge upside potential. Canaccord Genuity slashed the price target on Enovis Corporation (NYSE:ENOV) to $50 from $58 on December 17 and maintained a Buy rating o... Full story
Yahoo Finance • 4 months ago
An Enovis (ENOV) Insider Bets Big on the Stock With a Purchase of 2,468 Shares
Key Points John Kleckner reported an open market purchase of Enovis Corporation shares on Nov. 25, 2025. Kleckner is the principal accounting officer at Enovis Corporation.These 10 stocks could mint the next wave of millionaires › John K... Full story
Yahoo Finance • 5 months ago
ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 b... Full story
Yahoo Finance • 5 months ago
Enovis raises 2025 adjusted EPS guidance to $3.10–$3.25 while sharpening portfolio focus
Earnings Call Insights: Enovis Corporation (ENOV) Q3 2025 MANAGEMENT VIEW * CEO Damien McDonald highlighted the company's "solid third quarter results reflect strong performance broadly across the portfolio as we increasingly focus on... Full story
Yahoo Finance • 5 months ago
Enovis Corporation beats top-line and bottom-line estimates; updates FY25 outlook
* Enovis Corporation press release [https://seekingalpha.com/pr/20296140-enovis-announces-third-quarter-2025-results] (ENOV [https://seekingalpha.com/symbol/ENOV]): Q3 Non-GAAP EPS of $0.75 beats by $0.10. * Revenue of $549M (+8.7% Y/Y... Full story
Yahoo Finance • 5 months ago
Enovis Announces Third Quarter 2025 Results
Diversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organically Third-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organically October divestiture of Diabetic Foot... Full story
Yahoo Finance • 5 months ago
Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc.
This article first appeared on GuruFocus. Exploring Diamond Hill Capital (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Warning! GuruFocus has detected 4 Warning Sign with AIG. Is AIG fairly valued? Test your thesis with our free DC... Full story
Yahoo Finance • 5 months ago
Enovis Corporation Q3 2025 Earnings Preview
* Enovis Corporation (ENOV [https://seekingalpha.com/symbol/ENOV]) is scheduled to announce Q3 earnings results on Thursday, November 6th, before market open. The consensus EPS Estimate is $0.65 [https://seekingalpha.com/symbol/ENOV/earn... Full story
Yahoo Finance • 6 months ago
Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences
Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today it will host an investor conference call and live webcas... Full story
Yahoo Finance • 6 months ago
13 Top Stocks With Huge Upside Potential To Buy Now
Buying stocks when the market is setting all-time highs can be a bit nerve-wracking. On the one hand, markets often continue to make new highs once they break through to new records. Conversely, nothing goes up in a straight line. After ba... Full story
Yahoo Finance • 6 months ago
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story
Yahoo Finance • 6 months ago
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business t... Full story
Yahoo Finance • 7 months ago
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:3... Full story
Yahoo Finance • 8 months ago
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story
Yahoo Finance • 8 months ago
UBS Lowers PT on Enovis Corporation (ENOV) to $57 From $65, Keeps a Buy Rating
Enovis Corporation (NYSE:ENOV) is one of the best medical device stocks to buy according to analysts. On August 8, UBS lowered the firm’s price target on Enovis Corporation (NYSE:ENOV) to $57 from $65, keeping a Buy rating on the shares.... Full story
Yahoo Finance • 8 months ago
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2... Full story
Yahoo Finance • 8 months ago
ENOV December 2026 Options Begin Trading
Investors in Enovis Corp (Symbol: ENOV) saw new options become available today, for the December 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 494 days u... Full story
